FDA Inspection 904835 — Regional Women's Health Group, LLC

Regional Women's Health Group, LLC — FEI 3004088908

The FDA completed an inspection of Regional Women's Health Group, LLC on November 19, 2014 in Marlton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 19, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Marlton, NJ (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1249321 CFR 1271.90(c)Eligibility not required--warning labels